ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0441

Use of an Integrated Care Management Program to Uncover and Address Social Determinants of Health for Individuals with Lupus

Kreager Taber1, Jessica Williams1, Weixing Huang2, Katherine McLaughlin1, Christine Vogeli3, Rebecca Cunningham1, Lisa Wichmann1 and Candace Feldman4, 1Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, 3Massachusetts General Hospital, Boston, MA, 4Brigham and Women's Hospital, Boston

Meeting: ACR Convergence 2020

Keywords: Access to care, Disparities, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Healthcare Disparities in Rheumatology (0439–0443)

Session Type: Abstract Session

Session Time: 4:00PM-4:50PM

Background/Purpose: The burden of systemic lupus erythematosus (SLE) falls disproportionately on racial/ethnic minorities and individuals of lower socioeconomic status who often receive fragmented, inconsistent care. The Integrated Care Management Program (iCMP) enrolls patients at high risk for acute care use and adverse outcomes and connects them with a nurse and care team who help coordinate their medical care. We studied SLE patients enrolled in iCMP to understand whether social determinants of health (SDoH) needs such as food insecurity, housing instability, and financial constraints were prevalent in this population. We hypothesized iCMP teams would uncover and address SDoH issues that while likely present, would not have been documented before enrollment.

Methods: The iCMP enrolls the top 2% of medically and psychosocially complex patients within our multihospital primary care practices. Patients are identified by a system that incorporates clinical complexity, healthcare utilization indicators, and consultation with primary care providers, but does not explicitly factor in SDoH. Individuals with SLE enrolled in iCMP were identified with a validated machine learning algorithm (PPV=90%) and verified by chart review. We reviewed patients’ electronic health record encounters to identify SDoH needs prior to iCMP enrollment primarily using notes from physicians and social workers, and throughout enrollment using notes from iCMP nurses and team members.

Results: There were 69 patients with SLE enrolled in iCMP. Of these, 93% were female, 55% were white, 25% black, 3% Asian/Pacific Islander, 16% other/unknown race, and 21% were Hispanic. The mean duration of iCMP enrollment was 3.8 (SD 2.4) years. Prior to iCMP enrollment, 57% of the patients had documentation of ≥1 SDoH factor, compared to 94% during enrollment (Figure). The iCMP nurses addressed ≥1 SDoH factor for 81% of the SLE patients and completed high risks assessments for each patient. For these patients, iCMP nurses discussed and addressed multiple SDoH issues including medication access (66%), transportation (61%), insurance (50%), financial issues (48%), housing concerns (46%) and food insecurity (32%) (Table). The iCMP nurses connected 75% of these patients with additional resources, including social workers/mental health resources (58%), home health (43%) and elder care (14%) services, pharmacists (14%) and substance abuse programs (6%).

Conclusion: While SDoH-related issues were not used to identify patients for iCMP, the majority of enrolled high-risk, medically complex SLE patients had these needs. The iCMP nurses and care team members uncovered and addressed numerous SDoH-related concerns that while likely present, had not been documented prior to iCMP participation. As SDoH directly impact the care that patients access and the disproportionate burden of adverse outcomes among vulnerable populations, the healthcare system must develop and expand sustainable strategies like this integrated care management program to identify, document, and address these issues.  


Disclosure: K. Taber, None; J. Williams, None; W. Huang, None; K. McLaughlin, None; C. Vogeli, None; R. Cunningham, None; L. Wichmann, None; C. Feldman, Merck, 5, Voyager Therapeutics, 5, Biogen, 8.

To cite this abstract in AMA style:

Taber K, Williams J, Huang W, McLaughlin K, Vogeli C, Cunningham R, Wichmann L, Feldman C. Use of an Integrated Care Management Program to Uncover and Address Social Determinants of Health for Individuals with Lupus [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/use-of-an-integrated-care-management-program-to-uncover-and-address-social-determinants-of-health-for-individuals-with-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-an-integrated-care-management-program-to-uncover-and-address-social-determinants-of-health-for-individuals-with-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology